% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Hasselblatt:143578,
author = {M. Hasselblatt and C. Thomas and K. Nemes and C.-M.
Monoranu and M. J. Riemenschneider and A. Koch and D.
Sumerauer and P. Hauser and W. Paulus and P. Johann$^*$ and
M. Kool$^*$ and M. C. Frühwald},
title = {{T}yrosinase immunohistochemistry can be employed for the
diagnosis of atypical teratoid/rhabdoid tumours of the
tyrosinase subgroup ({ATRT}-{TYR}).},
journal = {Neuropathology $\&$ applied neurobiology},
volume = {46},
number = {2},
issn = {1365-2990},
address = {Oxford [u.a.]},
publisher = {Wiley-Blackwell},
reportid = {DKFZ-2019-01158},
pages = {186-189},
year = {2020},
note = {2020 Feb;46(2):186-189},
abstract = {Atypical teratoid/rhabdoid tumour (ATRT) is a malignant
brain tumour mainly occurring in young children [1].
Mutations of chromatin remodelling complex member
SMARCB1/INI1 or (rarely) SMARCA4/BRG1 are the sole recurrent
genetic lesions [2, 3]. On an epigenetic level, however,
ATRT is a heterogeneous disease comprised of three different
molecular subgroups (ATRT-TYR, ATRT-SHH and ATRT-MYC). This
article is protected by copyright. All rights reserved.},
subtyp = {Letter},
cin = {B062 / HD01},
ddc = {610},
cid = {I:(DE-He78)B062-20160331 / I:(DE-He78)HD01-20160331},
pnm = {312 - Functional and structural genomics (POF3-312)},
pid = {G:(DE-HGF)POF3-312},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:31077608},
doi = {10.1111/nan.12560},
url = {https://inrepo02.dkfz.de/record/143578},
}